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Clinicians should be 
cautious
when using clinical 
measures to make 
inferences about 
Natural Walking 
Behavior 
in people with 
Parkinson disease.
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INTRODUCTION
• Declines in the amount and intensity of natural walking 
behavior in people with PD may precede declines in motor 
behavior, gait and balance. 
• Yet clinicians may be more likely to rely on quick 
performance measures of walking speed, capacity, and 
balance to make inferences about walking health, rather 
than employ direct measures of natural walking behavior.
METHODS
• Baseline assessment for prospective clinical trial.
• 58 participants with PD: 
- 34 Male  / 24 Female
- 67.7 ± 8.0 years
- H&Y 2.0-3.0
• Clinical Measures: 
- Walking speed (10MWT, 10m Walk Test, m/s)
- Walking distance (6MWT, 6 Minute Walk Test, m)
- Dynamic balance (MBT, Mini-BESTest, total score)
• Natural Walking Behavior: Step Activity Monitor x 7 days
- Amount (mean daily steps, #) 
- Moderate Intensity (mean daily minutes of ³ 100 steps, #) 
• Post-hoc sub groups: 
- More active (³7.5K daily steps; n = 26)
- Less active (<7.5K daily steps; n = 32)
RESULTS
How Well Do Clinical 
Walking Measures 
Predict Natural Walking 
Behavior in  People With 
Parkinson disease? 
PRESENTER:
10MWT 6MWT MBT
Steps
Full sample .27 (.04) .38 (.003) .22 (.09)
More active -.18 (.37) -.06 (.77) -.09 (.66)
Less active .19 (.29) .28 (.12) .20 (.28)
Mod-intensity
Minutes
Full sample .20 (.14) .49 (<.01) .13 (.35)
More active -.25 (.21) .18 (.39) .01 (.96)
Less active .30 (.10) .48 (.006) .07 (.70)
Relationships Between Clinical & Walking Behavior Measures*
*Spearman’s rho (p value) 
DISCUSSION
• 55.2% of the sample accumulated < 7,500 steps / day.
• Only two par icipan s achieved recommended levels of 
moderate intensity physical activity via walking behavior.
• Clinical walking measures appear to be relatively poor 
candidates for predicting the amount or intensity of 
natural walking behavior.
- Only some participants with relatively robust walking 
speed, capacity, or balance were more active.
- Only some participants with relatively diminished 
walking speed, capacity, or balance were less active.
- The 6MWT appeared to show potential as a modest 
predictor of walking behavior – especially the walking 
intensity of relatively less active individuals.
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Descriptives !(SD) Full Sample More Active Less Active
10 MWT (m/s) 1.15 (0.23) 1.2 (0.24) 1.1 (0.20)
6MWT (m) 447.6 (98.5) 484.0 (76.3) 418.0 (105.4)
MBT (score) 19.0 (3.6) 19.9 (2.9) 18.3 (3.9)
Steps 7,666 (3843) 10,723 (3502) 5,183 (1751)
Mod-intensity 
Minutes
7.4 (9.6) 12.1 (11.6) 3.6 (5.2)
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